Advanced-nuclear and fusion founders need investors who can evaluate engineering milestones and long development cycles. These 15 providers include dedicated capital and broader firms with documented nuclear or fusion investments.
Use this list to build a focused research queue. Start with your company’s stage, the evidence you have and the milestone the round should finance. Then choose a small set of relevant providers, confirm the current mandate and plan an appropriate first conversation.
Advanced nuclear and fusion capital at a glance
This is a selective, unranked directory of 15 provider families. A venture fund, angel network, co-investor and growth or strategic investor can serve different company needs. The scope column records geographic, institutional or investment-stage context, not a claim that every organization is headquartered locally.
| Provider | Capital route | Investment scope |
|---|---|---|
| Nucleation Capital | Advanced-nuclear venture firm | Nuclear and carbon-management innovation |
| DCVC | Deep-technology venture firm | Science and engineering businesses |
| Energy Impact Partners | Energy investment platform | Nuclear enabling software and deployment businesses |
| Khosla Ventures | Frontier-technology venture firm | Fusion and other transformative technologies |
| Chrysalix | Industrial innovation venture firm | Industrial technology, including fusion |
| Chevron Technology Ventures | Corporate venture investor | Lower-carbon technology and industrial innovation |
| DeepTech & Climate Fonds | Deep-tech and climate investment fund | Technology-company growth capital |
| Future Ventures | Seed and early-stage technology venture firm | Frontier science and fusion |
| Lowercarbon Capital | Climate technology venture firm | Companies reducing carbon emissions |
| Andreessen Horowitz / American Dynamism | Technology venture strategy | Industrial, energy and national-capability technology |
| Cherry Ventures | European technology venture firm | Fusion investment evidence within wider technology investing |
| Balderton Capital | European technology venture firm | European companies, including fusion |
| UVC Partners | European deep-tech venture firm | Technology-company investment evidence |
| Plural | European founder-led venture platform | Science-led company building |
| redalpine | European science and technology venture firm | Fusion and other technology companies |
Separate the technology company from a power project
- Identify fission, fusion, enabling equipment or nuclear-sector software as the actual business.
- Map independently testable engineering milestones and major development dependencies.
- Separate company equity from plant construction, offtake and project financing; use qualified specialists for applicable regulatory questions.
Illustrative example: a fusion-component startup has repeatable bench results and a test customer. It seeks company capital for qualification and manufacturing validation. It does not present a commercial power station as already financeable or claim that an investor's past fusion deal guarantees current interest.
Avoid this shortcut: Fusion Fund is a technology investor brand, not proof of a fusion-energy mandate. Its branded search volume is excluded from this article's demand estimate.
15 providers to research
1. Nucleation Capital
Advanced-nuclear venture firm. Nuclear and carbon-management innovation.
Nucleation explicitly identifies advanced nuclear and carbon-management technologies as its venture focus. Nucleation Capital official information.
Prepare before outreach: Use the company financing route, not the fund subscription route, and explain the next engineering and commercial milestone.
2. DCVC
Deep-technology venture firm. Science and engineering businesses.
DCVC's current investment news includes Radiant and its nuclear-microreactor development activity. DCVC official information.
Prepare before outreach: Explain the specific reactor or enabling-system business, technical evidence and development dependencies; do not generalize from one portfolio company.
3. Energy Impact Partners
Energy investment platform. Nuclear enabling software and deployment businesses.
EIP's portfolio describes Atomic Canyon's nuclear-sector software and Elementl Power's advanced-nuclear development business. Energy Impact Partners official information.
Prepare before outreach: Distinguish a software venture, equipment company and project developer before choosing the investment strategy.
4. Khosla Ventures
Frontier-technology venture firm. Fusion and other transformative technologies.
Khosla's current portfolio includes Commonwealth Fusion Systems and Realta Fusion with descriptions of their fusion approaches. Khosla Ventures official information.
Prepare before outreach: Show reproducible engineering progress and a credible next milestone, not only a long-term power-generation ambition.
5. Chrysalix
Industrial innovation venture firm. Industrial technology, including fusion.
Chrysalix's current portfolio identifies General Fusion and its fusion-energy development work. Chrysalix official information.
Prepare before outreach: Use that as evidence of sector experience and confirm the current fund and stage rather than assuming every nuclear technology is in scope.
6. Chevron Technology Ventures
Corporate venture investor. Lower-carbon technology and industrial innovation.
Chevron's current venture page lists TAE Technologies and Zap Energy among its technology investments. Chevron Technology Ventures official information.
Prepare before outreach: Clarify the strategic application, applicable fund and investment process; investment interest is separate from a corporate purchase.
7. DeepTech & Climate Fonds
Deep-tech and climate investment fund. Technology-company growth capital.
Proxima Fusion's 2025 financing announcement names DeepTech & Climate Fonds among its investors. DeepTech & Climate Fonds official information.
Prepare before outreach: Check the current company and geographic criteria and match the financing to an independently testable development milestone.
8. Future Ventures
Seed and early-stage technology venture firm. Frontier science and fusion.
Future's current materials identify nuclear fusion among areas of recent investment and describe Commonwealth Fusion among its founding investment stories. Future Ventures official information.
Prepare before outreach: Explain the difficult technical insight and company-building path, while confirming which current partner and vehicle apply.
9. Lowercarbon Capital
Climate technology venture firm. Companies reducing carbon emissions.
Lowercarbon's current portfolio highlights Commonwealth Fusion Systems and its fusion-magnet technology. Lowercarbon Capital official information.
Prepare before outreach: Connect the startup's defensible technology to a credible commercialization path; an existing fusion investment does not establish an unrestricted mandate.
10. Andreessen Horowitz / American Dynamism
Technology venture strategy. Industrial, energy and national-capability technology.
American Dynamism's current materials include portable nuclear microreactors among its portfolio technologies. Andreessen Horowitz / American Dynamism official information.
Prepare before outreach: Explain the operating user and deployment environment, and identify relevant engineering and specialist regulatory dependencies.
11. Cherry Ventures
European technology venture firm. Fusion investment evidence within wider technology investing.
Cherry's current Proxima Fusion article describes co-leading the 2025 round and participating again in a later financing. Cherry Ventures official information.
Prepare before outreach: Treat the transaction as demonstrated experience; check present stage and competitive fit before approaching the team.
12. Balderton Capital
European technology venture firm. European companies, including fusion.
Balderton's current company directory lists Proxima Fusion and its 2025 Series A investment. Balderton Capital official information.
Prepare before outreach: Bring the European company connection and a focused technical-development plan; not every deep-tech sector is automatically a fit.
13. UVC Partners
European deep-tech venture firm. Technology-company investment evidence.
Proxima Fusion's June 2025 primary announcement names UVC Partners as an investor in its fusion financing. UVC Partners official information.
Prepare before outreach: Verify the current mandate and prepare evidence relevant to your own technical approach.
14. Plural
European founder-led venture platform. Science-led company building.
Proxima Fusion identifies Plural among the investors in its 2025 financing. Plural official information.
Prepare before outreach: Explain the company-building challenge and relevant European connection; a named transaction is not an open offer of financing.
15. redalpine
European science and technology venture firm. Fusion and other technology companies.
Proxima Fusion names redalpine as a participating investor and identifies it as the prior seed-round lead. redalpine official information.
Prepare before outreach: Show the scientific evidence, team and next financing milestone, and confirm current fund and geographic fit.
Turn the directory into your next five research actions
Choose five providers with a plausible mandate match, not five familiar logos. For each one, keep a source and one unresolved fit question beside the next action. Leave unknown information blank until you can verify it.
A compact investor-fit worksheet
Copy one record per provider. Replace the bracketed fields with company-specific evidence.
Advanced nuclear and fusion investor research
Provider: [name and specific fund]
Official source + checked date: [URL, date]
Why our stage and technology fit: [evidence]
Geographic or institutional connection: [evidence]
Milestone this round finances: [specific result]
Open fit question: [one question]
Introduction or founder route: [verified route]
Fission, fusion, component or software lane: [evidence or unknown]
Engineering milestone and dependencies: [evidence or unknown]
Company equity versus project capital: [evidence or unknown]
Owner + next action + date: [person, action, date]
Decision: [research next / ask a question / hold]Move a provider forward when the current mandate and your company evidence match. Ask a question when one material criterion is unclear. Hold when the fund is at the wrong stage, serves a different company geography or expects evidence you do not yet have. Do not treat a contact record as investor interest.
Give Aurora, Claude or Codex a focused research mission
Use this prompt with Aurora in Finta, Claude or Codex. Add only material you are authorized to share. Review the result before adding records or contacting anyone.
Be my Advanced nuclear and fusion investor-research teammate.
Company: [one sentence, stage and location]
Technology or business model: [specific scope]
Evidence we have: [authorized facts only]
Next financing milestone: [result to fund]
Focus checks: Fission, fusion, component or software lane; Engineering milestone and dependencies; Company equity versus project capital
Candidates: [paste five provider names from this guide]
Check each provider's current official sources.
Return: fit evidence, source URL/date, one open question, next action.
Separate local presence, investment reach and eligibility.
Mark missing facts unknown; do not invent cheque sizes or contacts.
Check portfolio conflicts before suggesting sensitive material.
Draft a research queue only. Do not contact or submit to anyone.Keep the next step moving
A useful shortlist connects investor fit to a relationship owner and a specific next action. Use Finta’s investor-prospecting workflow to organize the research. Keep the official source, contact context and follow-up together in your fundraising pipeline.
Before asking for an introduction, review portfolio conflicts and prepare a relevant message. The warm-introduction guide explains how to make a clear, permission-aware request. A possible path is not a completed introduction or a financing commitment.
Related research: Use the linked official provider sources to confirm the current mandate.
A common founder question
Is all advanced-nuclear capital interchangeable?
No. Reactor development, components, software and project development have different evidence, timelines and capital requirements.
How this list was researched
Research reviewed on October 29, 2026 using the linked official investment, portfolio and program pages. We count related firms and vehicles as one provider family where noted. Order is not a performance ranking. Public mandate evidence does not establish uncommitted capital, an open application window or an offer to invest; confirm the current process directly. The cover is an illustrative ecosystem, not a literal map or an investor-network diagram.
Authored by Finta Editorial Team. Source review was AI-assisted; hypothetical examples are labelled illustrative and are not customer results.
Informational guidance
This content is for general informational and educational purposes, not personalized investment, financial, legal or tax advice. Finta is not a law firm. Consult your attorney or accountant about financing documents, eligibility, intellectual property, tax treatment and your company’s circumstances.